• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: MS

Natalizumab use in late pregnancy

February 19, 2020  

New drug approvals in 2020

February 5, 2020  

MS prognosis – 30-year follow-up

January 22, 2020  

Sequencing MS therapies – a changing landscape

December 17, 2019  

Sequencing MS therapies – a changing landscape

December 17, 2019  

Future look: Drug approvals pending for 2020

December 5, 2019  

Progression independent of relapses (PIRA) in MS

November 21, 2019  

MULTIPLE SCLEROSIS – THE YEAR IN REVIEW

November 12, 2019  

PML reported in patient newly-treated with ocrelizumab

October 30, 2019  

Are opinions changing on changing therapies in MS?

October 22, 2019  
Previous
20
21
22
23
24
Next

Browse by Topic

  • MS (442)
  • EAN 2026 (2)
  • CLINICAL CASES (21)
  • AAN 2026 (3)
  • ACTRIMS Forum 2026 (4)
  • EPILEPSY (38)
  • AES 2025 (1)
  • BIOMARKERS IN MS (61)
  • ECTRIMS 2025 (7)
  • Library (18)
  • EAN 2025 (2)
  • AAN 2025 (5)
  • ACTRIMS 2025 (6)
  • AES 2024 (1)
  • ECTRIMS 2024 (6)
  • EAN 2024 (3)
  • AD (85)
  • AAN 2024 (5)
  • ACTRIMS Forum 2024 (2)
  • PD (77)
  • COVID-19 (58)
  • MIGRAINE (25)
  • DEPRESSION (36)
  • STROKE (22)
  • SCHIZOPHRENIA (25)
  • DEMENTIA (10)
  • SLEEP (2)
  • PAIN (3)
  • BPD (4)
  • ALS (1)

Popular Posts

  • Anti-CD20 therapy in MS: comparing efficacy and safety posted on July 21, 2026
  • Highlights of EAN 2026 – Part 1 posted on June 30, 2026
  • Proton pump inhibitors linked to neurological conditions posted on November 29, 2019
Copyright 2026 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions